Top segments and regional performance

Last year, the company generated ‪36.30 M‬ USD, the most of which — ‪36.31 M‬ USD — came from its top-performing segment, Pharmaceutical, compared to ‪34.87 M‬ USD the previous year. The greatest contribution came from United States and Canada, which accounted for ‪36.31 M‬ USD last year, with ‪34.87 M‬ USD the year before.